Expert review and recommendations for the management of acute, chronic, and neuropathic pain in Qatar

Joint Authors

al-Muhin, Amr
Nazzal, Abd Allah F.
Zubaydi, Uthman
Siddiqui, Urooj A.
al-Hatu, Muhammad

Source

Qatar Medical Journal

Issue

Vol. 2021, Issue 2 (31 Aug. 2021), pp.1-16, 16 p.

Publisher

Hamad Medical Corporation

Publication Date

2021-08-31

Country of Publication

Qatar

No. of Pages

16

Main Subjects

Pharmacy, Health & Medical Sciences

Abstract EN

Background: Pain management is an evolving area of expertise in Qatar.

Gaps in knowledge, inadequate training for physicians and nurses, and the absence of policies/guidelines are the main barriers to effective pain management in Qatar.

In addition, the use of certain pain medication, especially opioids, is highly regulated, limiting their availability in outpatient pain management.

These factors are responsible for the undertreatment of pain in Qatar.

This study aimed to standardize evidence-based local recommendations for pharmacological treatment of pain in Qatar.

Methods: An expert panel of physicians from different disciplines, with experience in diagnosis and treatment of the three pain types (i.e., acute, chronic, and neuropathic), was convened for two face-to-face meetings in Doha, Qatar, on November 29, 2019, and on February 22, 2020, with subsequent virtual meetings.

A literature search was performed on Medline and Google Scholar databases from inception till December 2019, and all relevant articles were selected.

Based on these articles and repeated feedback from the authors, the final pain treatment protocols were developed.

Results: Recommendations for the treatment of acute pain, based on pain severity, followed three approaches: acetaminophen/paracetamol or non- steroidal anti-inflammatory drugs (NSAIDs) for mild pain and moderate pain and referral to a pain specialist for severe pain.

Acetaminophen/paracetamol or NSAIDs is recommended for chronic pain, and the use of opioids was strongly discouraged because of its long-term side effects.

For neuropathic pain, tricyclic antidepressants or gabapentin or pregabalin or serotonin-norepinephrine reuptake inhibitors were recommended first-line agents.

Non-responders must be referred to neurologists or a pain specialist.

Conclusion: The expert panel provides recommen- dations for the management of acute, chronic, and neuropathic pain based on international guidelines adapted to local practice and treatment availability in Qatar.

More importantly, the panel has recommended taking extreme caution in the use of opioids for long- term management of chronic pain and to refer the patient to a pain specialist clinician as required.

American Psychological Association (APA)

al-Muhin, Amr& Nazzal, Abd Allah F.& Zubaydi, Uthman& Siddiqui, Urooj A.& al-Hatu, Muhammad. 2021. Expert review and recommendations for the management of acute, chronic, and neuropathic pain in Qatar. Qatar Medical Journal،Vol. 2021, no. 2, pp.1-16.
https://search.emarefa.net/detail/BIM-1442257

Modern Language Association (MLA)

al-Muhin, Amr…[et al.]. Expert review and recommendations for the management of acute, chronic, and neuropathic pain in Qatar. Qatar Medical Journal No. 2 (2021), pp.1-16.
https://search.emarefa.net/detail/BIM-1442257

American Medical Association (AMA)

al-Muhin, Amr& Nazzal, Abd Allah F.& Zubaydi, Uthman& Siddiqui, Urooj A.& al-Hatu, Muhammad. Expert review and recommendations for the management of acute, chronic, and neuropathic pain in Qatar. Qatar Medical Journal. 2021. Vol. 2021, no. 2, pp.1-16.
https://search.emarefa.net/detail/BIM-1442257

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references : p. 10-16

Record ID

BIM-1442257